Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

Money may soon start trickling in from a nearly decade-long legal battle with pharmaceutical companies accused of conspiring ...

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...

Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts ...